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Abstract 
Objective: We aimed to describe the prevalence and age distribution of personality disorders 
(PDs) and their comorbidity with other psychiatric disorders in an age-stratified sample of 
Australian women aged ≥25 years.  
Methods: Individual PDs (paranoid, schizoid, schizotypal, histrionic, narcissistic, borderline, 
antisocial, avoidant, dependent, obsessive-compulsive), and lifetime mood, anxiety, eating, 
and substance misuse disorders were diagnosed utilizing validated semi-structured clinical 
interviews (SCID-I and SCID-II). The prevalence of PDs and Clusters were determined from 
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the study population (n=768), and standardised to the Australian population using the 2011 
Australian Bureau of Statistics census data. Prevalence by age and the association with mood, 
anxiety, eating and substance misuse disorders was also examined. 
Results: The overall prevalence of PDs in women was 21.8% (95%C18.7, 24.9). Cluster C 
PDs (17.5%, 95%CI 16.0, 18.9) were more common than Cluster A (5.3%, 95%CI 3.5, 7.0) 
and Cluster B PDs (3.2%, 95%CI 1.8, 4.6). Of the individual PDs, obsessive-compulsive 
(10.3%, 95%CI 8.0, 12.6), avoidant (9.3%, 95%CI 7.1, 11.5), paranoid (3.9%, 95%CI 3.1, 
4.7) and borderline (2.7%, 95%CI 1.4, 4.0) were among the most prevalent. The prevalence 
of other PDs was low (≤1.7%). Being younger (25-34 years) was predictive of having any PD 
(OR 2.36, 95%CI 1.18, 4.74), as was being middle-aged (OR 2.41, 95%CI 1.23, 4.72). 
Among the strongest predictors of having any PD, was having a lifetime history of 
psychiatric disorders (OR 4.29, 95%CI 2.90, 6.33) and psychiatric hospitalisation (OR 3.48; 
95%CI 1.71, 7.07), respectively. Mood and anxiety disorders were the most common 
comorbid lifetime psychiatric disorders. 
 
Conclusions: Approximately one in five women were identified with a PD, emphasising that 
PDs are relatively common in the population. A more thorough understanding of the 
distribution of PDs and psychiatric comorbidity in the general population is crucial to assist 
allocation of health care resources to individuals living with these disorders. 
Keywords: personality disorder, prevalence, epidemiology, comorbidity, psychiatry 
Introduction 
Currently, little is known regarding the prevalence, distribution and associated 
characteristics of personality disorder (PD) and their comorbidity with other psychiatric 
disorders in the general Australian population. Clinically-based evidence indicates that PDs 
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are highly prevalent (45.5%) among psychiatric patients (Zimmerman et al., 2005), and are a 
consistent driver of impairments in social and occupational functioning (Gunderson et al., 
2011; Zanarini et al., 2012), and a key risk factor for suicide-attempts (Ansell et al., 2015; 
Zanarini et al, 2008). Despite the high levels of psychiatric comorbidity and associated 
functional impairment reported among those with PD in clinically-based studies, these 
comorbidities have remained largely unmeasured in the general Australian population.  
European population-based studies have shown the prevalence of PD to range 
between 4.4% (England, Scotland, and Wales) (Coid et al., 2006) and 13.4% (Norway) 
(Torgersen et al., 2001). The World Health Organization (WHO) Mental Health Surveys 
from Western European countries suggest that the pooled prevalence for any probable PD 
cases is approximately 6.1% (Huang et al., 2009). In the United States (US), the prevalence 
of PD has been reported to range between 9.0% and 21.5%, being somewhat higher than 
other countries (Grant et al., 2008; Grant et al., 2004; Lenzenweger et al., 2007; Pulay et al., 
2009; Stinson et al., 2008; Trull et al., 2010). Despite methodological heterogeneity, these 
population-based studies demonstrate that not only are PDs common, but they are also 
associated with overall disability (Grant et al., 2004; Jackson and Burgess, 2002; Trull et al., 
2010), disruptions to employment, reduced income, poor social functioning (Coid et al., 
2009; Lenzenweger et al., 2007; Sareen et al., 2011; Trull et al., 2010; Yang et al., 2010), and 
premature mortality (Fok et al., 2012). 
It is also well known that sex disparities exist in mental health, namely depression and 
anxiety, with approximately one in three Australian women being affected in their lifetime 
(Williams et al., 2010). There is a suggestion that some individual PDs might be particularly 
prevalent among women, for example obsessive-compulsive and avoidant PDs (Grant et al., 
2004; Jackson and Burgess, 2000; Torgersen et al., 2001; Trull et al., 2010); however, further 
research is needed.  
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To date, the prevalence of PDs among the general Australian population has been 
informed by the 1997 National Survey of Mental Health and Wellbeing (NSMHW). Jackson 
and Burgess reported that 6.5% of the Australian population (6.1% in women) screened 
positive for PD using the International Personality Disorder Examination (IPDE) screening 
questionnaire (59 items; true/false) (Jackson and Burgess, 2000). This survey also 
emphasised the significant disability associated with PD, underscored by frequent self-
reported utilization of health-care services (Jackson and Burgess, 2002; Jackson and Burgess, 
2004). The survey was limited by the restricted age-range assessed and by the use of a 
screening questionnaire to identify PD, which was later described as being too brief to 
adequately detect cases and not validated for this purpose (Jackson and Burgess, 2000). 
Good quality epidemiological data are vital for increasing the knowledge base of the 
healthcare sector, and thus guiding public health planning and delivery of services. Of equal 
importance, is information regarding the distribution and presentation of mental ill-health 
across the lifespan (Newton-Howes et al., 2015). Given the paucity of current and robust 
epidemiological data, we aimed to report the prevalence and age distribution of PD, PD 
clusters, and individual PDs, along with comorbid mood, anxiety, substance, and eating 
disorders, in a representative, age-stratified sample of Australian women aged ≥25 years. 
Methods 
Participants 
This study examined data collected from women enrolled in the Geelong 
Osteoporosis Study (GOS), an on-going, population-based cohort study originally established 
to describe the epidemiology of osteoporosis in Australia. The scope of the study has since 




Study participants were originally selected at random (1993-1997) from the 
Commonwealth of Australia Electoral Commission (AEC) rolls for the Barwon Statistical 
Division (BSD) located in south-eastern Australia, using an age-stratified sampling method. 
The BSD is representative of the wider Australian population in terms of pertinent socio-
demographic profiles (Pasco et al., 2012).  
Originally, 1,494 women participated in GOS baseline assessments (1994-1997), and 
an additional sample of 246 was recruited (2006-2008) aged 20-29 years using the same 
sampling method (Pasco et al., 2012). Further details of the study have been published 
elsewhere (Pasco et al., 2012; Williams et al., 2010). Of the remaining women who were 
eligible to participate, 849 returned for the assessment phase conducted 2011-2014. Reasons 
for non-participation included death (n=392), migration from the region (n=94) or inability to 
be contacted (n=128). Of the remaining 1,126 eligible participants, 277 women declined to 
participate citing the follow reasons: personal reasons (e.g. interference from family, invasion 
of privacy, not interested) (n=124), old age/unable to cope (n=78), time constraints (n=36), 
illness (n=21), too far to travel (n=5), failure to keep appointment (n=4), language barrier 
(n=1), and for reasons not provided (n=8). 
Of those 849 women, 768 provided complete Structured Clinical Interview for 
Diagnostic and Statistical Manual of Mental Disorders (DSM) Axis I Disorders, non-patient 
edition (SCID-I/NP) and Structured Clinical Interview for DSM-IV Axis II personality 
disorders (SCID-II) data and were thus included in the current analyses. Ethics approval was 
provided by the Barwon Health Human Research Ethics Committee, and Deakin University 




DSM-IV-TR psychiatric diagnoses were obtained using validated semi-structured 
clinical interviews (First et al., 1997; First et al., 2002). Reliability studies using a 
combination of joint interview and observer methods have shown the SCID I (Zanarini et al., 
2000) and SCID-II yields fair to good reliability ranges for categorical diagnoses (Maffei et 
al., 1997; Zanarini et al., 2000). Reliability coefficients (kappa for test-retest design) for the 
SCID have been shown to demonstrate fair agreement for categorical diagnoses of DSM-IV 
major depressive disorder (ϰ=0.61), poor (generalised anxiety disorder; ϰ=0.44) through good 
range for anxiety disorders (ϰ=0.59-0.78), good ranges for alcohol and other substance use 
disorders (ϰ=0.76-0.77) and fair for eating disorders (ϰ=0.64) (Zanarini et al., 2000). The 
presence of categorical PDs including avoidant, dependent, obsessive-compulsive, paranoid, 
schizotypal, schizoid, histrionic, narcissistic, borderline and antisocial was determined using 
the SCID-II (First et al., 1997). Reliability studies using joint interview and observer methods 
have shown the SCID-II yields fair-good reliability ranges for categorical diagnoses of the 
DSM-IV personality disorders: avoidant (ϰ=0.83-0.97), dependent (ϰ=0.83-0.86), obsessive-
compulsive (ϰ=0.83-0.87), paranoid (ϰ=0.93), schizoid (ϰ=0.91), schizotypal (ϰ=0.91), 
histrionic (ϰ=0.92), narcissistic (ϰ=0.98), borderline (ϰ=0.91), (ϰ=0.78-0.98) (Zanarini et al., 
2000; Maffei et al., 1997).  
Interviews were conducted by personnel with postgraduate qualifications in 
psychology, who were trained under the supervision of a psychiatrist using live and 
videotaped interviews as recommended by First et al. The SCID-I/NP was used to assess the 
presence of lifetime: 
i) mood disorders i.e., major depressive disorder (MDD), minor depression, 
dysthymia, mood disorder due to a general medical condition, substance induced 
mood disorder or bipolar disorder [I, II, not otherwise specified (NOS)];  
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ii) anxiety disorders i.e., panic disorder, agoraphobia, social phobia, specific phobia, 
obsessive-compulsive disorder, generalised anxiety disorder (current only), 
anxiety disorders due to a general medical condition, substance induced anxiety 
disorder and anxiety disorders NOS 
iii) eating disorders i.e., anorexia/bulimia nervosa, binge eating disorder  
iv) substance use disorders i.e., alcohol and non-alcohol substance use disorders  
(dependence and abuse) 
The SCID-II was used to assess the lifetime presence of: 
v) personality disorders i.e., paranoid, schizotypal, schizoid, histrionic, narcissistic, 
borderline, antisocial, avoidant, dependent, and obsessive-compulsive 
The Global Assessment of Functioning Scale (GAF) was used to measure aspects of 
functional capacities across psychological, social, and occupational domains (First et al., 
1997). 
Socio-demographic information 
Pertinent socio-demographic information was ascertained from self-reported 
questionnaires and included: age, country of birth, marital status, and completion of 
secondary education. The Index of Relative Socio-economic Advantage and Disadvantage 
(IRSAD) was used to determine the relative socioeconomic conditions of individuals and 
households at the area-level, as previously published (Brennan et al., 2009; Williams et al., 
2011). ABS software was utilised to derive the Socio-Economic Index For Areas (SEIFA) 
scores, providing a summary index that indicates both relative advantage and disadvantage at 
the small geographically defined area-level. A lower score on the IRSAD indicated relatively 
greater disadvantage (Quintile 1), and a higher score indicated relatively greater advantage 




Participants provided detailed lists and/or containers of current and prior use of 
medications, which were categorized according to the classification system of MIMS 
pharmaceutical database (MIMS Australia Pty Ltd, 2015). Height and weight were measured 
to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index [BMI (kg/m2)] was derived 
from these measures, with obesity being defined having a BMI >30 kg/m2. Information 
regarding history of psychiatric hospitalisations was also collected during the interviews. 
Statistical analyses 
“Any PD” was generated by the presence of any one or more categorical PDs; 
“Cluster A” included any categorical paranoid, schizotypal, or schizoid PDs; “Cluster B” any 
categorical histrionic, narcissistic, borderline, or antisocial PDs; “Cluster C” any categorical 
avoidant, dependent, or obsessive-compulsive PDs (American Psychiatric Association, 2013). 
Age-stratified frequencies for any PD, Clusters, and individuals PDs were determined for 10-
year age groups (25-34, 35-44, 45-54, 55-64, 65-74, ≥75 years). Unadjusted Odd Ratios (OR) 
with 95% confidence intervals (95%CI) for the predictor variables of interest (age groups, 
socioeconomic status, marital status, education, birth country, psychotropic medication use, 
obesity, psychiatric hospitalization, and lifetime psychiatric disorders) were calculated using 
logistic regression. Cross tabulations were used to examine the frequencies (n=) and 
percentage (%) of women with any PD for each predictor variable. The dependent variable 
was presence of “any PD”. Differences between those with and without any PD on GAF 
scores were assessed using Kruskal Wallis, with median and inter quartile range (IQR) 
reported. Values of p<0.05 were accepted as statistically significant. The overall prevalence 
estimates (with 95%CI) of any PD, Clusters and individual PDs were determined from the 
study population and directly standardized to the population at risk for each age group using 
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the Australian Bureau of Statistics 2011 census data (Age by Sex; Cat. No.2001.0; Australian 
Bureau of Statistics, 2012; Kirkwood & Sterne, 2003). Statistical analyses were performed 
using Minitab Statistical Software (Version 17; Minitab, State College, PA, USA) and Stata 
Statistical Software (Release 13. StataCorp LP, College Station, TX, USA). 
 Results 
The frequencies and percentage of women with any PD according to each predictor 
variable of interest are presented in Table 1. The proportion of women with PD in each age 
group were as follows: 26.4% (25-34 years); 21.7% (35-44 years), 26.8% (45-54 years), 
21.0% (55-64 years), 14.4% (65-74 years), 13.2% (≥75 years) (Table 1).  It can be seen that 
the youngest age group (25-34 years) was associated with increased odds of having any PD 
(p<0.01), as was the middle age group (45-54 years) (p<0.01). Other significant predictors of 
having any PD were psychotropic medication use (current), psychiatric hospitalisation (ever), 
obesity (ever), being single/never married, or separated/divorced (all p<0.01). The strongest 
predictors of having any PD was having a lifetime history of psychiatric disorders (all 
p<0.01). There was also a difference in GAF scores between those with any PD (70.0; IQR 
60.0-80.0) compared to those without (85.0; IQR 80.0-90.0) as measured by the GAF Scale 
(p<0.001); suggesting those with any PD had higher functional impairment.  
After standardisation, the overall prevalence of any PD in Australian women was 
21.8% (95%CI= 18.7, 24.9) (Figure 1). Cluster C PDs were the most prevalent with 17.5% 
(95%CI= 16.0, 18.9), followed by Cluster A with 5.3% (95%CI= 3.5, 7.0) then Cluster B 
with 3.2% (95%CI= 1.8, 4.6). Of the individual PDs, obsessive-compulsive and avoidant PDs 
were the most common with 10.3% (95%CI= 8.0, 12.6) and 9.3% (95% CI=7.1, 11.4) 
meeting criteria respectively, followed by: paranoid 3.9% (95%CI= 3.1, 4.7), borderline 2.7% 
(95%CI= 1.4, 4.0), schizotypal 1.7% (95%CI= 0.7, 2.7), schizoid 1.0% (95%CI= 0.2, 1.7), 
11 
 
and dependent 0.8% (95%CI= 0.16, 1.3). We detected too few cases of narcissistic (n=4) and 
antisocial (n=1) PDs to calculate standardized prevalence estimates for these individual 
categories, and there were no cases of histrionic PD.  
Frequencies of co-occurring PDs according to individual PD categories are presented 
in Table 2. Furthermore, of those identified with any PD (n=157), 73.2% (n=115) reported a 
lifetime history of psychiatric disorders. Mood disorders were the most prevalent comorbidity 
(63.7%; n=100), followed by anxiety disorders (45.2%; n=71). Other comorbidities reported 
by those with a PD included: eating (11.5%; n=18), alcohol use (7.6%; n=12) and non-
alcohol substance use (6.4%; n=10) disorders.  
Discussion 
This study provides information regarding the prevalence, age distribution and 
comorbidity associated with PDs in a population-based sample of women. The key findings 
to emerge from these data were: i) approximately one in five women were estimated to have a 
PD; ii) PDs were most prevalent among the younger and middle-aged  groups, and; iii) mood 
and anxiety disorders were the most prevalent comorbid lifetime psychiatric disorders among 
those with PDs as well as other co-occurring PDs. These data highlight that PDs are relatively 
common among the general population, and that there is a significant burden of associated 
psychiatric comorbidity. 
Data from US population-based studies utilizing semi-structured clinical interviews 
also suggest that the prevalence of PDs ranges between 9.0% and 21.5% (Grant et al., 2008; 
Grant et al., 2004; Pulay et al., 2009; Stinson et al., 2008; Trull et al., 2010). The National 
Epidemiologic Survey on Alcohol and Related Conditions (n=43,093; ≥18 years) yielded a 
prevalence of 21.5% (pooled from two cross-sectional Waves) using the Alcohol Use 
Disorder and Associated Disability Schedule-IV (Grant et al., 2008; Grant et al., 2004; Pulay 
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et al., 2009; Stinson et al., 2008); although this was substantially reduced (9.0%) when more 
stringent criteria for PD was utilised (Trull et al., 2010). The National Comorbidity Survey-
Replicated (NSC-R) screened population-based respondents using the International 
Personality Disorder Examination (IPDE) screener and interviewed a probability sub-sample 
(n=214) with a semi-structured clinical interview yielding a prevalence of 9.1% for any PD 
(Lenzenweger et al., 2007). In a series of semi-structured clinical interviews administered as 
part of the longitudinal Children in the Community study, the cumulative prevalence of PD 
had reached 28% in adults by mean age of 33 years (14.6% mean age 14 years, 18.1% 16 
years, 22 years 25.7%) (Johnson et al., 2008).  In Norway, a household survey of respondents 
recruited from the National Register Oslo (n=3,590; 18-65 years) yielded a prevalence of 
13.4% for any PD using the Structured Interview for DSM-III-R Personality administered by 
experienced health care providers (Torgersen et al., 2001). 
Considerably lower prevalence estimates have also been reported. The household 
survey of United Kingdom (UK) of Great Britain (England, Wales and Scotland), reported a 
prevalence  of 4.4% (3.4% for women only) in a sample of 628 men and women aged 16-65 
years, using the same diagnostic tool as was utilised in the current study (Coid et al., 2006). 
Our prevalence data are also markedly higher than previous studies utilising screening 
instruments (Jackson and Burgess, 2000; Huang et al., 2009), with the heterogeneity among 
instruments and interviewers likely to explain some of the variation in prevalence reported. 
The higher prevalence of less severe forms of PD such as obsessive-compulsive PD and the 
lower prevalence of more severe forms of PD that were detected in the current study, might 
be another reason for the discrepancies. 
Individual personality disorders 
13 
 
Consistent with the studies from the US, UK, and Norway, Cluster C PDs were more 
prevalent, than Clusters A or B PDs (Coid et al., 2006; Lenzenweger et al., 2007; Torgersen 
et al., 2001). Specifically, our data are concordant with prior studies that have demonstrated 
that obsessive-compulsive and avoidant are the most prevalent PDs among women in the 
general population (Grant et al., 2004; Jackson and Burgess, 2000; Torgersen et al., 2001; 
Trull et al., 2010). In fact, the overall prevalence of PDs in the current study was largely 
attributable to cases of obsessive-compulsive PD (10.3%). Clinically-based data also indicate 
that obsessive-compulsive, avoidant, and borderline PDs are among the most common PDs in 
psychiatric patients receiving treatment (Zimmerman et al., 2005).   
Prior studies have reported that the prevalence of obsessive-compulsive PD among 
women ranges between 1.3-7.9% (Jackson and Burgess, 2000; Coid et al., 2006; Grant et al., 
2004). Given the nature of obsessive-compulsive PD, continued participation in research 
studies such as the GOS, might be expected and might account for the overrepresentation of 
this PD in the current study. Furthermore, obsessive-compulsive PD features have been 
shown to be more stable over time compared with other PDs and mental state disorders such 
as MDD (Grilo et al., 2004).  Inconsistent associations between obsessive-compulsive PD 
and disability have been previously reported (Grant et al., 2004), suggesting that both higher 
and lower functioning individuals with this disorder can meet threshold criteria. Clinically-
based data also indicates that whilst patients with obsessive-compulsive PD show little 
improvement over time on measures of psychosocial functioning, these patients suffered less 
impairment compared with other PDs (Skodol et al., 2005).  
In contrast, borderline PD is considered a severe form of PD, which was found to be 
similar (2.7%) to what has been previously reported. A prior examination of PD in an 
Australia population-based study of younger adults (n=1520; mean age 24.1 years), indicated 
the prevalence of borderline PD (assessed using the ICD-10 version of the Standardised 
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Assessment Personality) was 3.5% (n=1145; any PD 18.6%), with more young women being 
identified than young men (Moran et al., 2006).  
Avoidant PD was more prevalent in our study than the previously reported range of 
0.7-2.76% (Coid et al., 2006; Grant et al., 2004; Jackson and Burgess, 2000). One possible 
explanation might be associated with the central feature of this disorder being “a desire to be 
accepted, despite hypersensitivities to rejection” (American Psychiatric Association, 2013). 
Most of the participants enrolled in the GOS have participated in numerous follow-up 
appointments, thereby potentially reducing perceived potential dangers or threats. 
Furthermore, given the high comorbidity and criterion overlap between avoidant PD and 
anxiety disorders, in particular social phobia, it is possible that some cases of avoidant PD 
might have been better accounted for by social phobia.  On the whole, it remains likely that 
Cluster C PD features such as a desire to please and perfectionism might drive higher rates of 
retention in a long-term cohort study. On the other hand, high impulsivity and related Cluster 
B features might result in low retention in this study, providing a falsely low prevalence. For 
example in the current study, fewer individuals with avoidant or obsessive-compulsive PDs 
had more than one co-occurring PD – suggesting that comorbidity might be a driver of illness 
severity and thus potentially influence participation. It is also likely that the low prevalence 
of antisocial PD in the current study are due to sex differences, with other studies reporting 
the prevalence of antisocial PD being higher among men (Lenzenwerger et al., 2006). 
Cluster A PDs were the next most prevalent as a group, with paranoid PD being the 
most common in this Cluster (5.3%). This pattern was similarly reported in the NSC-R 
(Lenzenweger et al., 2007), Great Britain Household Survey (Coid et al., 2006) and the 
NESARC (Grant et al., 2004); however our study reported higher prevalence for each PD 
Cluster. Still, consistent with these prior studies, the prevalence of the remaining individuals 
PDs in the current study was low (all ≤1.7%). Whilst Cluster A PDs have been shown to be 
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more prevalent than Cluster B PDs, the latter have received greater attention, and Cluster A 
PDs remain relatively under-studied in general population settings. 
Age distribution 
In the present study, a higher proportion of PDs were observed among the younger 
age group as well as the middle-aged group. Prior studies have also reported that those with 
PD tend to be younger (Coid et al., 2006; Jackson and Burgess, 2000; Torgersen et al., 2001). 
Until recently, there have been few studies examining the prevalence of PD across the full 
adult lifespan. Data from the NESARC reported age-stratified prevalence for PDs among 
adults aged 55 years and over (women: 16.1% 55-64 years; 11.6% 65-74 years; 9.4% 75-84 
years, 8.7% 85+ years) (Reynolds et al., 2015).  
The features characteristic of Cluster B PDs, such as symptoms and behaviours 
associated with impulsivity and affective instability have been shown to be particularly 
characteristic among younger adults (Zanarini et al., 2008), and are susceptible to a 
fluctuating course (Gunderson et al., 2011; Zanarini et al., 2012; Zanarini et al., 2008), 
suggesting “burn out” of these behavioural features over time. A number of studies have 
further highlighted the clinical differences between the presentation of symptoms among 
younger adults who present with borderline PD including impulsivity, affective instability 
and increased severity of symptoms being associated with younger age (Yang et al., 2010; 
Zanarini et al., 2008); in contrast, older adults appear more likely to experience chronic 
emptiness, and reduced features of impulsivity and affective instability (Morgan et al., 2013). 
Other clinical-based studies indicate that Cluster C PD features are more enduring (Ferro et 
al., 1998; Grilo et al., 2004; Durbin and Klein, 2006).  
A higher proportion of women aged 45-54 years were also more likely to have any 
PD in the current study. Developmentally, there are many domains that might be related to 
16 
 
personality pathology among women in this age group including physical health, social 
relationships, and major life experiences (Oltmanns & Balsis, 2011).  Finally, increasing age 
is a known risk factor for poorer physical functioning and physical morbidity. Physical 
health problems and psychiatric comorbidity are also commonly reported among older adults 
(El-Gabalawy et al., 2011). It is possible that the higher prevalence of PD observed in the 
current sample, might be associated with poorer physical health status. Currently, one can 
only speculate upon the developmental trajectory of PD across lifespan from the current 
cross-sectional data, with longitudinal analyses needed to investigate age-related patterns as 
they emerge from adolescence through to middle and older adulthood.  
Lifetime comorbidities 
Among those with any PD, the lifetime comorbidity with any mental state disorder in 
the present study was 73.3%, concordant with prior Australian data reporting 40.9%-77.8% 
(Jackson and Burgess, 2002). We identified mood (63.7%) and anxiety disorders (45.2%) as 
the most common comorbidity disorders, being consistent with previous clinical- 
(Zimmerman et al., 2005) and population-based data (Jackson and Burgess, 2000). We also 
reported comorbid alcohol and other non-alcohol substance use disorders (7.7% and 6.4%, 
respectively). According to the clinically-based US Collaborative Longitudinal Personality 
Disorders Study, up to 85% of those with PDs are reported to suffer from mood disorders, 
particularly recurrent MDD (Gunderson et al., 2008). Conversely, the clinically-based (n=391 
outpatients) Rhode Island Methods to Improve Diagnostic Assessment and Services study 
(Zimmerman et al., 2005) reported that 31.4% of the patients with mood disorders and other 
psychiatric conditions had at least one PD. 
In the current study, those with PD also reported a markedly higher proportion of 
comorbid lifetime eating disorders compared with those without PD (11.5% v 2.8%). In 
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comparison with other psychiatric disorders, the investigation of comorbid eating disorders 
has received less attention. Interestingly, a study examining consecutive patients receiving 
treatment for eating disorders (n=545, ages 18-54years) found that certain PD features were 
more common among specific sub-types of eating disorders than others (Godt, 2008). Godt 
(2008) found that Cluster B PDs were more common (15.1%) among those with bulimia 
nervosa - purging type, Cluster C PDs more common (28.6%) among those with bulimia 
nervosa - non-purging-type, whereas the prevalence of Cluster A PDs was relatively low 
(≤2.3%) across all subtypes of eating disorders. 
Sociodemographic correlates  
Consistent with several population-based studies (Jackson and Burgess, 2000; Coid et 
al., 2006; Huang et al., 2009; Torgersen et al., 2001), being single/never married or 
separate/divorced was predictive of having any PD. They also tended to be more socially 
disadvantaged (not significant). Others have reported that those with PD are particularly 
likely to be living in urban areas (Coid et al., 2006; Torgersen et al., 2001), face 
unemployment, and have lower levels of educational attainment (Coid et al., 2006; Jackson 
and Burgess, 2000; Torgersen et al., 2001).  
Strengths and limitations 
A major strength of the current study is the comprehensive psychiatric assessments 
that were used to identify PDs and psychiatric comorbidities. Additionally, we investigated a 
random, age-stratified, population-based sample, spanning the full adult age-range. We also 
utilised a robust measure of relative advantage and disadvantage (IRSAD) that extends prior 
studies that have relied on self-reported information alone to measure socioeconomic status. 
However it is possible that a response bias may exist, given the higher proportion of PDs 
observed in quintiles 1 and 2.  As such, the current study provides a valuable contribution to 
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the literature given the paucity of good quality epidemiological data derived from the general 
Australian population.  
There are also potentially important limitations to consider when interpreting our data. 
First, the psychiatric profile of GOS non-respondents may have differed from responders. 
Also, we cannot exclude the possibility of differential loss to follow-up, in relation to PDs, 
over the course of the study. These factors combined might have impacted on how well our 
sample represented the underlying population. The reduced sample for which complete 
psychiatric data was available, may have further introduced bias. Our sample might also 
differ to the underlying population in terms of patterns of migration and cultural diversity. 
Given that there is a paucity of prior data collected utilising the same assessment tool, 
comparisons of our data with other populations in Australia should be made with caution. 
Furthermore, we cannot rule out that both recall and information bias were introduced when 
administering the semi-structured clinical interviews, despite strict adherence to protocols. 
For example, standard questioning requires the participants to recall experiences over their 
lifetime, and the nature of recalling past events might have led to differential 
misclassification. The interviewers’ qualifications and level of experience may also have 
introduced measurement error. Moreover, precision of the overall prevalence estimates, 
particularly among less frequent PDs as well as predictor variables with smaller frequencies, 
must be interpreted with caution. Furthermore, others have suggested there might be a sub-
group of individuals with PD in the general population that are higher functioning, 
characterised by absence of comorbidity with other mental disorders and help-seeking 
behaviours (Coid et al., 2009; Jackson and Burgess, 2000). The current study has provided 
prevalence estimates for categorical diagnoses only; it is acknowledged that this doesn’t 
provide a complete picture regarding the dimensions of PD severity in our study. Therefore, 
caution should be taken when interpreting our findings and anticipating the future health care 
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needs of individuals with PD with varying levels of symptom severity and needs. Whilst we 
provided a comprehensive assessment of psychiatric disorders, psychotic and cognitive 
disorders were not assessed. Lastly, these data are cross-sectional, thereby precluding 
examination of the longitudinal trajectory of PD.  
Future directions and conclusions 
First, complementary data are needed regarding the prevalence of PD among 
Australian men. Second, further investigations are warranted regarding associations between 
PD clusters, and individual PDs with mental state disorders, particularly eating disorders, 
where there are few data. There also remains a need for more in-depth investigations into the 
socioeconomic profile of PD among both women and men, in order to further identity sub-
groups of the population who might be at risk of PD, and also to understand the needs of 
those with PD living with social disadvantage. Finally, we suggest that further investigations 
are required regarding the associated disability among those with PD in the general 
Australian population, as well psychiatric and physical comorbidities and associated help-
seeking behaviours, in order to address needs for therapeutic intervention (Quirk et al., 2015), 
which will be explored in separate analyses. In conclusion, these data emphasise that PDs are 
relatively common among the Australian population, and provides much needed 
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Table 1: Frequencies (n=) and percentage (%) of women with any personality disorder for each predictor variable, and logistic regression model 
for predicting PD presented as odds ratio (OR) with 95% confidence intervals (CI)  
Predictor variables n= (%) total sample n= (%) with PD OR 95% CI p-value 
Age group, years       
25-34, years  106 (13.8%) 28 (26.4%) 2.36 1.18, 4.74 0.01 
35-44, years  115 (15.0%) 25 (21.7%) 1.70 0.90, 3.70 0.09 
45-54, years 127 (16.5%) 34 (26.8%) 2.41 1.23, 4.72 0.01 
55-64, years 167 (21.7%) 35 (21.0%) 1.75 0.91, 3.38 0.096 
65-74, years 139 (18.1%) 20 (14.4%) 1.11 0.54, 2.28 0.78 
≥75, yearsa  114 (14.8%) 15 (13.2%) - - - 
Socioeconomic status      
29 
 
Quintile 1 (most disadvantaged)a 116 (15.1%) 29 (25.0%) - - - 
Quintile 2 87 (11.3%) 20 (23.0%) 0.90 0.47, 1.72 0.74 
Quintile 3 295 (38.4%) 55 (18.6%) 0.69 0.41, 1.14 0.15 
Quintile 4 143 (18.6%) 30 (21.0%) 0.80 0.44, 1.43 0.44 
Quintile 5 127 (16.5%) 23 (18.1%) 0.66 0.36, 1.23 0.19 
Marital status      
Married/living with partner a 541 (70.4%) 101 (18.7%) - - - 
Single/never married 60 (7.8%) 18 (30.0%) 1.87 1.03, 3.37 0.03 
Separated/divorced 86 (11.2%) 28 (32.6%) 2.10 1.28, 3.47 0.004 
Widowed 81 (10.5%) 10 (12.3%) 0.61 0.31, 1.23 0.17 
Birth Country       
Australia and New Zealand a 667 (86.8%) 136 (20.4%) - - - 
30 
 
UK of Great Britain & Northern Ireland 53 (6.9%) 14 (26.4%) 1.40 0.73, 2.66 0.30 
Europe 38 (4.9%) 5 (13.2%) 0.59 0.23, 1.54 0.28 
Other 10 (1.3%) 2 (20.0%) 0.98 0.20, 4.65 0.97 
Education       
Did not complete secondary school 157 (20.4%) 56 (17.8%) 0.76 0.53, 1.09 0.13 
Obesity (ever) 244 (31.8%) 64 (26.2%) 1.65 1.15, 2.38 0.007 
Psychotropic medication use (current) 181 (24.1%) 54 (29.8%) 1.95 1.33, 2.86 0.001 
Psychiatric hospitalisation (ever) 33 (4.3%) 15 (45.5%) 3.48 1.71, 7.07 0.001 
Lifetime Psychiatric Disorders       
Any lifetime psychiatric disorder 353 (46.0%) 115 (32.6%) 4.29 2.90, 6.33 <0.001 
Lifetime mood disorder 292 (38.0%) 100 (34.2%) 3.83 2.65, 5.53 <0.001 
Lifetime anxiety disorder 180 (23.4%) 71 (39.4%) 3.80 2.61, 5.54 <0.001 
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Lifetime eating disorder 35 (4.6%) 18 (51.4)% 4.52 2.27, 9.00 <0.001 
Lifetime alcohol use disorder 16 (2.1%) 12 (75.0%) 12.56 3.99, 39.50 <0.001 
Lifetime non-alcohol substance use disorder 17 (2.2%) 10 (58.8%) 5.87 2.20, 15.68 <0.001 








Any includes individual personality disorders: paranoid, schizoid, schizotypal, narcissistic, 
borderline, antisocial, avoidant, dependent, and obsessive-compulsive 
 
Figure 1: Prevalence of personality disorders standardized to the Australian population 
(2011) (error bars represent 95% CI) 
Table 2: Frequency of co-occurring personality disorders according to individual personality 
disorder categories 
 
 1 PD 2 PDs 3 PDs ≥4 PDs 
Paranoid 11 (45.8%) 5 (20.8%) 2 (8.3%) 6 (25.0) 
Schizoid 3 (42.86%) 2 (28.6%) 1 (14.3%) 1 (14.3%) 
Schizotypal 3 (27.3%) 2 (18.2%) 2 (18.2%) 4 (36.4%) 
Narcissistic 1 (25.0%) 1 (25.0%) - 2 (50.0%) 
Borderline 5 (29.4%) 6 (35.3%) 2 (11.8%) 4 (23.5%) 
Antisocial - - 1 (100%) - 
Avoidant 47 (67.1%) 16 (22.9%) 3 (4.3%) 4 (5.7%) 















Dependent 4 (57.1%) - 1 (14.3%) 2 (28.6%) 
Obsessive-compulsive 46 (63.9%) 18 (25.0) 3 (4.2) 5 (6.9%) 
PD = personality disorder; row % 
